GURU.Markets stock price, segment price, and overall market index valuation
The company's share price DexCom Inc.
DexCom is a pioneer and leader in continuous glucose monitoring (CGM) technology. The company's explosive share price rise is a story of a technological revolution in diabetes treatment, freeing patients from painful finger pricks and giving them more control over their lives.
Share prices of companies in the market segment - Therapeutic medical equipment
DexCom is a leader in continuous glucose monitoring (CGM) systems for people with diabetes. We classify it as a Therapeutic Medical Equipment company. The chart below shows the overall dynamics of this rapidly growing market, where technology is changing the standard of care.
Broad Market Index - GURU.Markets
DexCom is a leader in the development and production of continuous glucose monitoring (CGM) systems for people with diabetes. Its innovations have earned it a spot in the GURU.Markets index. The chart below represents the market. See if DexCom is outperforming the overall trends in the medical technology sector.
Change in the price of a company, segment, and market as a whole per day
DXCM - Daily change in the company's share price DexCom Inc.
DexCom is a leader in the development and production of continuous glucose monitoring systems for people with diabetes. Its daily share price change is a measure of volatility in the medical technology sector. This metric, while not spectacular, is an important element in the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
The diabetes medical device sector, where DexCom, Inc. is a leader, is growing rapidly. This chart shows the average daily volatility of the entire MedTech industry. Comparing it to DXCM's performance helps us understand how the company's innovations allow it to stay ahead of industry trends.
Daily change in the price of a broad market stock, index - GURU.Markets
DexCom is a leader in continuous glucose monitoring (CGM) systems for people with diabetes. The diabetes medical device market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how DexCom shares respond to innovation and competition.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization DexCom Inc.
DexCom is the market leader in continuous glucose monitoring (CGM) systems for people with diabetes. Its year-over-year growth reflects the rapid growth of this technology, which is changing the lives of millions of patients. The chart below tells the story of this dominant position.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
DexCom, Inc. is a leader in the development of continuous glucose monitoring (CGM) systems for people with diabetes. Its technology is transforming the way the disease is treated. This chart shows how its innovative leadership and rapid growth in CGM adoption allow it to significantly outpace the medical device industry.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
DexCom is a leader in the development of continuous glucose monitoring (CGM) systems for people with diabetes. The company's growth is driven by technological superiority and the lack of CGM penetration. This powerful trend in healthcare makes DexCom a growth story unaffected by the economy.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization DexCom Inc.
The price of DexCom, a leader in continuous glucose monitoring systems, reflects the rapid adoption of its technology. Monthly fluctuations on the chart depend on data on new patient growth, insurance coverage expansion, and international expansion, indicating high growth potential.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
This chart illustrates the dynamics of the medical technology sector, particularly in diabetes treatment. For DexCom, a leader in continuous glucose monitoring, this provides context. Its rapid growth demonstrates how its technology is becoming a standard of care, outpacing the entire sector.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
DexCom is a leader in continuous glucose monitoring systems for diabetics. It is a fast-growing company in the healthcare sector. A chart of the overall market dynamics allows us to assess how strong DexCom's growth trend (driven by the introduction of its technology) allows the stock to defy overall market volatility and maintain its trajectory.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization DexCom Inc.
Shares of DexCom, a leader in glucose monitoring systems, are highly sensitive to medical innovation. Weekly fluctuations reflect news of new product approvals, clinical trial data, and competitor actions. This chart shows how the market perceives the company's technological superiority in the fight against diabetes.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
DexCom, a leader in continuous glucose monitoring, often sets trends in its medical device segment. This chart compares the company's performance with the broader sector, demonstrating how its innovation and growth allow it to outpace the industry even when overall sentiment in the healthcare sector is muted.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
DexCom is a leader in continuous glucose monitoring systems for diabetics. The company's growth is driven by medical needs and innovation. The chart shows how DexCom's stock price is unaffected by overall market fluctuations, riding the wave of its technology adoption.
Market capitalization of the company, segment and market as a whole
DXCM - Market capitalization of the company DexCom Inc.
DexCom's market capitalization chart visualizes the revolution in diabetes treatment. It reflects not just sales of medical devices, but investors' belief that continuous glucose monitoring technology will become a global standard. Every rise on this chart is a step toward a future where managing the disease will become simpler and more effective.
DXCM - Share of the company's market capitalization DexCom Inc. within the market segment - Therapeutic medical equipment
DexCom is a leader and pioneer in the development of continuous glucose monitoring (CGM) systems for people with diabetes. Its significant market share in the medical device sector speaks to its technological superiority and dominance in this rapidly growing market. The chart clearly shows how DexCom outperforms its competitors in this niche.
Market capitalization of the market segment - Therapeutic medical equipment
DexCom is the market leader in continuous glucose monitoring systems. The chart below shows the total market capitalization of the entire diabetes medical technology segment. Its rapid growth reflects the technological revolution in diabetes treatment and the enormous market potential.
Market capitalization of all companies included in a broad market index - GURU.Markets
Could a coin-sized device become a multi-billion dollar business? The charts of DexCom, a manufacturer of glucose monitoring systems, tell the story of how technology is changing the lives of people with diabetes. Its global market share reflects the growing value of personalized medicine and digital health.
Book value capitalization of the company, segment and market as a whole
DXCM - Book value capitalization of the company DexCom Inc.
DexCom manufactures medical devices, and its book value is derived from its production lines and R&D centers. The chart below shows how the company is expanding its inventory base for producing vital sensors. Its growth is a clear indication of its capacity expansion to meet demand.
DXCM - Share of the company's book capitalization DexCom Inc. within the market segment - Therapeutic medical equipment
DexCom produces glucose monitoring systems that transform the lives of people with diabetes. Its strength lies in its unique technologies, but mass production requires modern factories. The share price chart shows how the company is expanding its physical production base to meet global demand for its devices.
Market segment balance sheet capitalization - Therapeutic medical equipment
As the chart shows, medical equipment manufacturing is a capital-intensive industry. DexCom is a prime example. Mass production of its unique glucose monitoring systems requires state-of-the-art manufacturing facilities. The company is consciously investing in this physical base to meet global demand.
Book value of all companies included in the broad market index - GURU.Markets
DexCom creates devices that change the lives of people with diabetes. The company's assets include high-tech manufacturing facilities and laboratories where these vital sensors are created. The chart below illustrates the physical scale of the company, which creates "sensory organs" for health monitoring.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - DexCom Inc.
DexCom, Inc. is a leader in continuous glucose monitoring systems. Its massive market capitalization is a reward for its technological leadership, rapid growth, and the huge market of people with diabetes for whom its devices are life-changing.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
DexCom, Inc. is a leader in continuous glucose monitoring systems. Its value lies in its technology and patents, not its production capacity. This chart shows how its market valuation, reflecting expectations of growth and market dominance, is many times greater than the company's book value.
Market to book capitalization ratio for the market as a whole
DexCom is a leader in the development of continuous glucose monitoring systems for people with diabetes. The company's value is determined not by its product lines, but by its cutting-edge technology, patents, and ecosystem that changes the lives of millions. The chart shows how highly investors value this intellectual capital and its leadership in the rapidly growing medical technology market.
Debts of the company, segment and market as a whole
DXCM - Company debts DexCom Inc.
For DexCom, a pioneer in continuous glucose monitoring systems, debt is fuel for innovation and rapid growth. The company actively invests borrowed funds in R&D to create new generations of sensors and in global marketing. This chart shows how its financial strategy directly supports its expansion into the global diabetes device market.
Market segment debts - Therapeutic medical equipment
DexCom is a leader in continuous glucose monitoring systems for people with diabetes. This is a rapidly growing sector, requiring significant investment in R&D and marketing. The company's leverage reflects its commitment to maintaining its technological leadership and capturing market share. This chart shows how the company is funding its aggressive growth relative to the industry.
Market debt in general
DexCom, Inc. is a pioneer in the development of continuous glucose monitoring systems for people with diabetes. This is a rapidly growing sector, requiring ongoing investment in R&D and marketing. This chart provides insight into the overall investment climate within which DexCom is funding its innovations and global expansion, striving to maintain its technological leadership.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio DexCom Inc.
DexCom, a manufacturer of glucose monitoring systems, is in a phase of rapid growth and innovation, requiring significant investment. This chart shows how the company is funding its development. Debt can be a sign of confidence in future demand for its products, but it can also be a risk factor if competitors offer more advanced technologies.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
DexCom has revolutionized diabetes treatment with its glucose monitoring systems. This chart shows the debt burden in the therapeutic medical device sector. It helps understand how companies in the industry finance expensive innovations and clinical trials, and how DexCom's financial strategy fits into this high-tech market.
Debt to book value of all companies in the market
DexCom is a leader in glucose monitoring systems that transform the lives of people with diabetes. This chart shows the overall market leverage. It allows you to compare the financial model of a fast-growing innovative company requiring capital investment with the more conservative capital structure of mature companies in the economy.
P/E of the company, segment and market as a whole
P/E - DexCom Inc.
This chart for DexCom, Inc. shows the high market valuation of the leader in continuous glucose monitoring systems for people with diabetes. The company's profits are growing along with the expansion of its technology. The extremely high valuation suggests that investors are betting not on current revenue, but on the company's enormous growth potential for the future.
P/E of the market segment - Therapeutic medical equipment
DexCom develops and manufactures continuous glucose monitoring (CGM) systems for people with diabetes. The company's technology is transforming patients' quality of life. This chart illustrates the average valuation in the therapeutic medical devices sector, where investors highly value innovations that can create a new standard of care for chronic diseases.
P/E of the market as a whole
DexCom has revolutionized diabetes treatment with continuous glucose monitoring systems. The company's growth is driven by the penetration of its technology, not the state of the economy. This chart shows the overall market "temperature." Comparison with it demonstrates whether DexCom is considered a unique growth story in medicine, independent of market fluctuations, or whether it is also affected by general sentiment.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company DexCom Inc.
DexCom specializes in the development and production of continuous glucose monitoring systems for people with diabetes. This chart shows investor expectations for the company's future growth. The valuation is closely tied to the speed of adoption of its technologies, the expansion of insurance coverage, and innovations that make patients' lives easier and safer.
%20P%2FE%20DexCom%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-DexCom-Inc.&v=1772584140498 "Chart of the company's future (projected) P/E DexCom Inc.")
Future (projected) P/E of the market segment - Therapeutic medical equipment
DexCom develops and manufactures continuous glucose monitoring systems for people with diabetes. This chart compares the company's future profitability expectations with the medical device industry average. It helps understand how the market values their technological leadership and growth potential compared to other therapeutic device manufacturers.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772584140557 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
DexCom has revolutionized diabetes treatment with its continuous glucose monitoring systems. The company's success depends more on innovation and market penetration than on general economic cycles. This market expectations curve likely influences DexCom's valuation, as investors are willing to pay a premium for breakthrough technologies in the healthcare sector.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772584140640 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit DexCom Inc.
DexCom specializes in the development and production of continuous glucose monitoring (CGM) systems for people with diabetes. The company's profits are growing along with the expansion of its innovative devices, which replace traditional glucometers. This chart illustrates how technological breakthroughs in medicine can create new markets and generate stable revenue.
Profit of companies in the market segment - Therapeutic medical equipment
DexCom develops and manufactures continuous glucose monitoring (CGM) systems for people with diabetes. This chart shows the profitability of the therapeutic device sector. DexCom's technology is transforming patients' lives, and its widespread adoption is one of the main drivers of growth and innovation in the entire diabetes treatment industry.
Overall market profit
DexCom develops and manufactures continuous glucose monitoring systems for people with diabetes. This is a medical technology whose demand is driven not by economic conditions, but by healthcare needs and innovation. DexCom's success depends less on the cycles visible in this graph and more on improving patients' quality of life.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company DexCom Inc.
DexCom is a pioneer and leader in the development of continuous glucose monitoring (CGM) systems for people with diabetes. This chart shows analysts' forecasts for future revenue. Market expectations are directly linked to the adoption of CGM technology by patients and physicians, expanding insurance coverage, and the launch of new, more advanced generations of devices.
%20profit%20of%20the%20company%20DexCom%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-DexCom-Inc.&v=1772584140911 "Graph of future (projected) profit of the company DexCom Inc.")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
DexCom is a pioneer in the development of continuous glucose monitoring (CGM) systems for people with diabetes. This chart displays aggregate revenue forecasts for the entire therapeutic medical device industry. It highlights the expected growth of the diabetes technology market, a key factor in assessing DexCom's potential to expand its user base.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772584140981 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
DexCom has revolutionized diabetes care with its continuous glucose monitoring systems. Its business is driven by innovation and medical needs, but the economic backdrop, illustrated here, is significant. Growing economies and rising incomes facilitate patient access to advanced medical devices and ensure stable reimbursement from insurance companies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772584141071 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - DexCom Inc.
DexCom is a leader in the development and production of continuous glucose monitoring (CGM) systems for people with diabetes. The company's revenue is growing rapidly thanks to patients switching from traditional glucometers to its technology. This chart shows how highly investors value its sales, factoring in future market growth and the company's technological leadership.
P/S market segment - Therapeutic medical equipment
DexCom is a pioneer in the development of continuous glucose monitoring systems, transforming the lives of people with diabetes. This is a rapidly growing segment of medical equipment. The graph below shows the average revenue estimate for the industry, allowing us to see the premium the market is willing to pay for DexCom's technological leadership and the enormous growth potential of its products.
P/S of the market as a whole
DexCom develops and manufactures continuous glucose monitoring systems for people with diabetes. This is a rapidly growing market, and the company is one of its leaders. Its revenue is directly linked to innovation and technology penetration. This chart compares the high revenue estimates of the medical technology company with the more down-to-earth figures of companies in traditional sectors.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company DexCom Inc.
DexCom is a leader in the development of continuous glucose monitoring (CGM) systems for people with diabetes. The company's future revenue is directly dependent on the pace of adoption of its technologies and increased access to them through insurance coverage. This chart shows market expectations for the growing penetration of CGM devices and DexCom's market dominance.
%20P%2FS%20DexCom%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-DexCom-Inc.&v=1772584141214 "The graph of the company's future (projected) P/S DexCom Inc.")
Future (projected) P/S of the market segment - Therapeutic medical equipment
DexCom is a leader in the development and production of continuous glucose monitoring (CGM) systems for people with diabetes. This is a rapidly growing market driven by technological innovation and improving patient quality of life. This graph reflects investor expectations for DexCom's future sales, positioning it as a technology leader in the medical industry.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772584141251 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
DexCom is a pioneer in continuous glucose monitoring. The company's growth is fueled not so much by economic cycles as by innovation and technology penetration. However, the overall market optimism, evident in the chart, facilitates access to capital for R&D and increases healthcare systems' willingness to pay for advanced medical devices.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772584141278 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales DexCom Inc.
DexCom is a pioneer in the development of continuous glucose monitoring (CGM) systems for people with diabetes. The company's revenue comes from sales of its sensors and transmitters, which have revolutionized the way people manage their diabetes. This chart shows the growing demand for its innovative medical devices, reflecting the shift from traditional methods to digital healthcare.
Sales of companies in the market segment - Therapeutic medical equipment
DexCom is a pioneer in the development of continuous glucose monitoring (CGM) systems for people with diabetes. The company's revenue comes almost entirely from sales of its flagship devices and disposable sensors. This chart reflects the rapid growth of the diabetes medical technology market, where DexCom's innovative products are changing the quality of life for millions and setting a new standard of care.
Overall market sales
DexCom develops and manufactures continuous glucose monitoring systems for people with diabetes. This is a medical technology, the demand for which is primarily driven by health needs. However, this timeline is important because economic well-being affects insurance coverage and the availability of such advanced and expensive systems for millions of patients.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company DexCom Inc.
DexCom is a leader in the development and production of continuous glucose monitoring (CGM) systems for people with diabetes. The company's revenue growth is driven by the rapid adoption of its technologies worldwide. This chart reflects analyst forecasts for CGM market expansion and increased penetration of DexCom products, which directly drives future sales.
%20sales%20of%20the%20company%20DexCom%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-DexCom-Inc.&v=1772584141495 "Schedule of future (projected) sales of the company DexCom Inc.")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
DexCom is a pioneer and leader in the development of continuous glucose monitoring (CGM) systems for people with diabetes. The data presented provides a forecast for the entire therapeutic medical device market. Investors will need to assess how DexCom's technological superiority and expanded access to its products will enable the company to dominate the overall growth in demand.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772584141540 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
DexCom, Inc., a pioneer in continuous glucose monitoring systems, sees this chart as a reflection of the state of healthcare systems. Rising overall economic forecasts provide stable funding for healthcare providers and insurance companies. This facilitates the wider adoption of advanced technologies like DexCom devices to improve patients' quality of life.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772584141607 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality DexCom Inc.
DexCom develops and manufactures continuous glucose monitoring (CGM) systems for people with diabetes. Their success is based on technological leadership and the growing penetration of their devices. This chart illustrates how innovation in medical technology and strong patent positions enable the company to achieve high profitability in a rapidly growing market.
Market segment marginality - Therapeutic medical equipment
DexCom is a leader in the development and production of continuous glucose monitoring (CGM) systems for people with diabetes. This chart shows how profitable the production and sale of its medical devices are compared to competitors. This high figure reflects technological superiority, strong patent protection, and growing demand for its products.
Market marginality as a whole
DexCom is a leader in continuous glucose monitoring systems. The company operates in a rapidly growing medical technology market driven by innovation and demographics. Its growth trajectory may differ significantly from the overall market dynamics shown in the chart. It is a classic example of a growth company whose fate is decided in the lab, not on the stock exchange.
Employees in the company, segment and market as a whole
Number of employees in the company DexCom Inc.
DexCom is at the forefront of the fight against diabetes, producing continuous glucose monitoring systems. This chart illustrates the company's rapid growth. The increase in staff, particularly in sales, customer support, and R&D, is directly related to the rapid market penetration of its technology and the need to serve an ever-growing patient base worldwide.
Share of the company's employees DexCom Inc. within the market segment - Therapeutic medical equipment
DexCom is a pioneer and leader in the development of continuous glucose monitoring (CGM) systems for people with diabetes. This figure reflects the company's concentration of specialists in the narrow niche of diabetes medical equipment. It is a testament to its technological leadership and the scale of its efforts to improve the lives of millions of patients.
Number of employees in the market segment - Therapeutic medical equipment
DexCom, Inc. is a pioneer in the development of continuous glucose monitoring (CGM) systems for people with diabetes. This chart illustrates the growth of employment in the therapeutic medical device sector. The increase in the number of specialists here reflects technological advancements and the growing adoption of innovative devices that change patients' lives, and DexCom is leading this process.
Number of employees in the market as a whole
DexCom develops continuous glucose monitoring systems for people with diabetes. Their growth depends on the availability of medical technologies. Overall employment, reflected in the graph, influences the number of people with access to quality health insurance through their employer. The more stable the labor market, the more patients can afford DexCom's innovative devices.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company DexCom Inc. (DXCM)
DexCom revolutionized diabetes treatment with its continuous glucose monitoring systems. The high market capitalization per employee in this chart suggests that the market values technology and intellectual property above all else. A small team is creating a product that changes the lives of millions, and it is this innovative potential that drives the company's valuation.
%20of%20the%20company%20DexCom%20Inc.%20(DXCM)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-DexCom-Inc.-DXCM&v=1772584141837 "Chart of market capitalization per employee (in thousands of dollars) of the company DexCom Inc. (DXCM)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
DexCom (DXCM) is a leader in continuous glucose monitoring (CGM) systems for diabetics. It is a fast-growing MedTech company. Its value lies in its R&D and robust ecosystem. This chart shows the company's high market value per employee, reflecting its dominance in this technologically advanced medical niche.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772584141845 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
DexCom specializes in continuous glucose monitoring systems, transforming the lives of people with diabetes. This chart shows a high market valuation per employee, reflecting the value of their innovative technology and intellectual property. It demonstrates how technological breakthroughs in medicine create enormous shareholder value.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772584141855 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company DexCom Inc. (DXCM)
DexCom produces continuous glucose monitoring (CGM) systems for people with diabetes. This is a rapidly growing medical technology market. This chart shows how effectively the company is scaling its business. It reflects the profit generated by each employee, from R&D engineers to workers on high-tech assembly lines. This is an indicator of the profitability of their innovative products.
%20Chart%20DexCom%20Inc.%20(DXCM)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-DexCom-Inc.-DXCM&v=1772584141888 "Company Profit Per Employee (in thousands of dollars) Chart DexCom Inc. (DXCM)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
DexCom is a leader in continuous glucose monitoring (CGM) systems for diabetics. This chart shows the benchmark for "therapeutic medical equipment." In this sector, R&D is key. The average profit per employee reflects the balance between development costs and high-margin sales of consumables (sensors).
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772584141902 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
DexCom produces continuous glucose monitoring systems that change the lives of people with diabetes. This is a high-tech medical product that requires both extensive R&D and precision manufacturing. This graph illustrates how a team of scientists, engineers, and workers creates a high-value-added product, resulting in significant financial returns.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772584141943 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee DexCom Inc. (DXCM)
DexCom develops and manufactures continuous glucose monitoring systems for people with diabetes. This chart illustrates the MedTech sector's performance. The growth in revenue per employee reflects the high demand for their innovative products, automated manufacturing, and scaling of their business, which is transforming the lives of millions of patients worldwide.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-DexCom-Inc.-DXCM&v=1772584141957 "Sales chart per company employee DexCom Inc. (DXCM)")
Sales per employee in the market segment - Therapeutic medical equipment
DexCom is a leader in the development of continuous glucose monitoring (CGM) systems for diabetics. Their business encompasses R&D, hardware (sensor) production, and a subscription model (razor and blades). This chart shows the industry average revenue per employee. It helps assess the productivity of this high-tech medical model.
Sales per employee for the market as a whole
DexCom is a leader in continuous glucose monitoring (CGM) systems for people with diabetes. Their business is focused on medical devices with a "razor and blades" model (the sensors are consumables). This chart shows how their R&D team and production lines generate high recurring revenue from these life-saving gadgets.
Short shares by company, segment and market as a whole
Shares shorted by company DexCom Inc. (DXCM)
DexCom is a leader in continuous glucose monitoring (CGM) systems for people with diabetes. This is a rapidly growing medical technology market. This chart shows bearish bets. The short position may be driven by fierce competition from Abbott (Libre) and Medtronic, as well as concerns that new weight-loss drugs (GLP-1) will reduce the number of patients with type 2 diabetes, shrinking DexCom's addressable market.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-DexCom-Inc.-DXCM&v=1772584142005 "Short Shares Chart for the Company DexCom Inc. (DXCM)")
Shares shorted by market segment - Therapeutic medical equipment
DexCom (DXCM) is a pioneer and leader in the development of continuous glucose monitoring (CGM) systems for people with diabetes. This chart shows sentiment in the medical technology sector. Rising bets against the industry could signal investor concerns about increased competition or pressure from insurance companies on CGM device pricing, which is a key risk for DexCom.
Shares shorted by the overall market
DexCom revolutionized diabetes treatment with its continuous glucose monitoring (CGM) systems. It's a fast-growing sector of medtech. On the one hand, their products are vital. On the other, they're a growth stock with a high valuation. When fear rises in the market, as this chart shows, investors often sell off expensive growth stories, even strong ones like DexCom, in favor of cheaper assets.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator DexCom Inc. (DXCM)
DexCom is a leader in continuous glucose monitoring (CGM) systems. It's a classic "growth stock" in medical equipment. This chart measures momentum. "Overbought" (above 70) reflects euphoria from quarterly reports showing explosive growth or news of expanded insurance coverage. "Oversold" (below 30) indicates panic due to increased competition (Abbott) or price pressure.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-DexCom-Inc.-DXCM&v=1772584142138 "RSI 14 indicator chart for the company's stock DexCom Inc. (DXCM)")
RSI 14 Market Segment - Therapeutic medical equipment
DexCom (DXCM) is a pioneer in continuous glucose monitoring (CGM) for people with diabetes. The RSI_14_Seg for "Therapeutic medical equipment" (medtech) indicates whether the sector is overbought. This helps us understand whether DXCM's rise reflects recognition of its G7 technology or general overheating in the diabetes device sector.
RSI 14 for the overall market
DexCom revolutionized diabetes treatment with its continuous glucose monitoring (CGM) systems. It's a fast-growing company in the medical device sector. Demand for its products is medical, not cyclical. However, this chart shows the overall risk appetite. As a growth stock, DXCM is sensitive to market euphoria (overbought) or panic (oversold), which can impact its high valuation.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast DXCM (DexCom Inc.)
DexCom is a pioneer in continuous glucose monitoring (CGM) systems for people with diabetes. Its G6 and G7 devices have become industry standards. This chart shows analysts' assessments of the pace of CGM adoption, the company's ability to maintain technological leadership, and market expansion beyond patients with type 1 diabetes.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-DXCM-DexCom-Inc.&v=1772584142296 "A chart showing analyst consensus forecasts for the expected stock price. DXCM (DexCom Inc.)")
The difference between the consensus estimate and the actual stock price DXCM (DexCom Inc.)
DexCom is a leader in the development of continuous glucose monitoring (CGM) systems for people with diabetes. This chart shows the difference between the consensus forecast and the price. It reflects analysts' confidence in the growth of the CGM market and DexCom's ability to maintain its technological leadership (G7) against competitors.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-DXCM-DexCom-Inc.&v=1772584142326 "A chart showing the difference between the consensus forecast and the actual stock price. DXCM (DexCom Inc.)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
DexCom is a leader in continuous glucose monitoring (CGM) systems for people with diabetes. This is a rapidly growing MedTech market. This chart shows analysts' overall expectations for the medical device sector. It reflects whether experts believe diabetes technology will continue to see rapid adoption.
Analysts' consensus forecast for the overall market share price
DexCom is a pioneer in continuous glucose monitoring (CGM) systems for people with diabetes. Their technology is transforming patients' quality of life. This is a rapidly growing medical technology market. This chart shows the overall market sentiment. For DexCom, whose sales depend on technology adoption, it's important to understand how general economic expectations impact healthcare costs. (342)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index DexCom Inc.
DexCom is a company that has changed the lives of people with diabetes. They produce continuous glucose monitoring (CGM) systems that eliminate the need for constant fingersticks. This graph reflects the exponential adoption of their technology. It measures the growth in the number of users of their devices, which generate recurring revenue from the sale of consumables (sensors).
AKIMA Market Segment Index - Therapeutic medical equipment
DexCom is a pioneer and leader in a vital technology: continuous glucose monitoring (CGM) systems for people with diabetes. This aggregate metric evaluates companies. The chart shows the sector average. This benchmark: how does DexCom's technological leadership in wearable medicine (and its razor-like model) differentiate it from the average competitor?
The AKIM Index for the overall market
DexCom is a leader in the development of continuous glucose monitoring (CGM) systems for people with diabetes. This is a rapidly growing MedTech segment that is changing treatment standards. This chart, reflecting the market average, provides context. It helps assess how this growth story in the protective healthcare sector compares to the overall macroeconomic trends impacting markets.
